Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE

NCT03642561 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE: radiotherapy ablation
DEVICE: transarterial chemoembolization(TACE)

Sponsor

Fudan University